Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b

NCT00423644 is registered in ClinicalTrials.gov with Alaunos Therapeutics as lead sponsor.

NCT NCT00423644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00423644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b
Lead sponsor
Alaunos Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2007
Completion date
December 21, 2008
Enrollment
17 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma